Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

G.V. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandalà,G.V. Long, A. Hauschild, M. Santinami, V. Atkinson, M. Mandalà,V. Chiarion-Sileni, J. Larkin, M. Nyakas, C. Dutriaux, A. Haydon, C. Robert,L. Mortier, J. Schachter, D. Schadendorf, T. Lesimple, R. Plummer, R. Ji, P. Zhang,B. Mookerjee, J. Legos, R. Kefford, R. Dummer, and J.M. Kirkwood